Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607

The Hospital Anxiety and Depression Scale

Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089

International physical activity questionnaire: 12-country reliability and validity

CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Ossenkoppele, R., Pichet Binette, A., Groot, C., Smith, R., Strandberg, O., Palmqvist, S., Stomrud, E., Tideman, P., Ohlsson, T., Jögi, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02049-x · Cited by 496

Challenges and hopes for Alzheimer’s disease

Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291

The Future of Precision Medicine in the Cure of Alzheimer’s Disease

Arafah, A., Khatoon, S., Rasool, I., Khan, A., Rather, M. A., Abujabal, K. A., Faqih, Y. A. H., Rashid, H., Rashid, S. M., Bilal Ahmad, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020335 · Cited by 133

Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment

Strikwerda‐Brown, C., Hobbs, D. A., Gonneaud, J., St‐Onge, F., Binette, A. P., Ozlen, H., Provost, K., Soucy, J., Buckley, R. F., Benzinger, T. L. S., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.2379 · Cited by 134

Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease

Cadby, G., Giles, C., Melton, P. E., Huynh, K., Mellett, N. A., Duong, T., Nguyen, T. A., Cinel, M. A., Smith, A., Olshansky, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30875-7 · Cited by 108

Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials

Ossenkoppele, R., Salvadó, G., Janelidze, S., Binette, A. P., Bali, D., Karlsson, L., Palmqvist, S., Mattsson, N., Stomrud, E., Therriault, J., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00835-z · Cited by 144

CenTauR: Toward a universal scale and masks for standardizing tau imaging studies

Villemagne, V. L., Leuzy, A., Bohorquez, S. M. S., Bullich, S., Shimada, H., Rowe, C. C., Bourgeat, P., Lopresti, B. J., Huang, K., Krishnadas, N., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12454 · Cited by 72

Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform

Feizpour, A., Doecke, J. D., Doré, V., Krishnadas, N., Huang, K., Bourgeat, P., Laws, S. M., Fowler, C. J., Robertson, J. S., Mackintosh, L., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105405 · Cited by 79

Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease

Salvadó, G., Janelidze, S., Bali, D., Dolado, A. O., Therriault, J., Brum, W. S., Binette, A. P., Stomrud, E., Mattsson, N., Palmqvist, S., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.3217 · Cited by 88

Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation

Cummings, J. L., & Kinney, J. W. (2022) · Medicina · doi:10.3390/medicina58070952 · Cited by 61

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach

Morató, X., Pytel, V., Jofresa, S., Ruiz, A., & Boada, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169305 · Cited by 53

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study

Gardener, S. L., Rainey‐Smith, S. R., Villemagne, V. L., Fripp, J., Doré, V., Bourgeat, P., Taddei, K., Fowler, C. J., Masters, C. L., Maruff, P. T., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.744872 · Cited by 53

Understanding machine learning applications in dementia research and clinical practice: a review for biomedical scientists and clinicians

Wang, Y., Liu, S., Spiteri, A. G., Huynh, A. L. H., Chu, C., Masters, C. L., Goudey, B., Pan, Y., & Jin, L. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01540-6 · Cited by 48

Reduced cortical cholinergic innervation measured using [18F]-FEOBV PET imaging correlates with cognitive decline in mild cognitive impairment

Xia, Y., Eeles, E. M., Fripp, J., Pinsker, D. M., Thomas, P. A., Latter, M. J., Doré, V., Fazlollahi, A., Bourgeat, P., Villemagne, V. L., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102992 · Cited by 44

Detection of Alzheimer's disease using deep learning models: A systematic literature review

Mohammed, E. M., Fakhrudeen, A. M., & Alani, O. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101551 · Cited by 50

Bridging gaps between images and data: a systematic update on imaging biobanks

Gabelloni, M., Faggioni, L., Borgheresi, R., Restante, G., Shortrede, J. E., Tumminello, L., Scapicchio, C., Coppola, F., Cioni, D., Junquero, I. G.-R., et al. (2022) · European Radiology · doi:10.1007/s00330-021-08431-6 · Cited by 42

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study

Krishnadas, N., Doré, V., Robertson, J. S., Ward, L. D., Fowler, C. J., Masters, C. L., Bourgeat, P., Fripp, J., Villemagne, V. L., & Rowe, C. C. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104450 · Cited by 41

Plasma p‐tau181/Aβ 1‐42 ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ 1‐42 and future cognitive decline

Fowler, C. J., Stoops, E., Rainey‐Smith, S. R., Vanmechelen, E., Vanbrabant, J., Dewit, N., Mauroo, K., Maruff, P. T., Rowe, C. C., Fripp, J., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12375 · Cited by 36

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer’s Disease

Chatterjee, P., Doré, V., Pedrini, S., Krishnadas, N., Thota, R. N., Bourgeat, P., Ikonomović, M. D., Rainey‐Smith, S. R., Burnham, S. C., Fowler, C. J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220908 · Cited by 36

Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study

Doecke, J. D., Bellomo, G., Vermunt, L., Alcolea, D. A., Halbgebauer, S., Veld, S. G. J. G. I. ‘., Mattsson, N., Veverová, K., Fowler, C. J., Boonkamp, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14573 · Cited by 43

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Milicic, L., Vacher, M. A., Porter, T., Doré, V., Burnham, S. C., Bourgeat, P., Shishegar, R., Doecke, J. D., Armstrong, N. J., Tankard, R. M., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00558-8 · Cited by 33

A federated learning architecture for secure and private neuroimaging analysis

Stripelis, D., Gupta, U., Saleem, H., Dhinagar, N., Ghai, T., Anastasiou, C., Sánchez, R., Steeg, G. V., Ravi, S., Naveed, M., et al. (2024) · Patterns · doi:10.1016/j.patter.2024.101031 · Cited by 31

A systematic review on early prediction of Mild cognitive impairment to alzheimers using machine learning algorithms

Niyas, K. P. M., & Thiyagarajan, P. (2023) · International Journal of Intelligent Networks · doi:10.1016/j.ijin.2023.03.004 · Cited by 34

ENHANCE: a comparative prospective longitudinal study of cognitive outcomes after 3 years of hearing aid use in older adults

Sarant, J. Z., Busby, P. A., Schembri, A. J., Fowler, C. J., & Harris, D. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1302185 · Cited by 27

The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults

Sewell, K. R., Rainey‐Smith, S. R., Villemagne, V. L., Peiffer, J. J., Sohrabi, H. R., Taddei, K., Ames, D. J., Doré, V., Maruff, P. T., Laws, S. M., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114108 · Cited by 28

Independent study demonstrates amyloid probability score accurately indicates amyloid pathology

Fogelman, I., West, T., Braunstein, J. B., Verghese, P. B., Kirmess, K. M., Meyer, M. R., Contois, J. H., Shobin, E., Ferber, K. L., Gagnon, J., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51763 · Cited by 25

Validation of a digit symbol substitution test for use in supervised and unsupervised assessment in mild Alzheimer’s disease

Williamson, M., Maruff, P. T., Schembri, A. J., Cummins, H., Bird, L., Rosenich, E., & Lim, Y. Y. (2022) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2023.2179977 · Cited by 26

The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults

Sewell, K. R., Rainey‐Smith, S. R., Pedrini, S., Peiffer, J. J., Sohrabi, H. R., Taddei, K., Markovic, S. J., Martins, R. N., & Brown, B. M. (2024) · GeroScience · doi:10.1007/s11357-024-01130-2 · Cited by 25

Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β

Cespedes, M. I., Jacobs, K. R., Maruff, P. T., Rembach, A., Fowler, C. J., Trounson, B. O., Pertile, K. K., Rumble, R. L., Rainey‐Smith, S. R., Rowe, C. C., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105783 · Cited by 26

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum

Feizpour, A., Doré, V., Doecke, J. D., Saad, Z. S., Triana‐Baltzer, G., Slemmon, R., Maruff, P. T., Krishnadas, N., Bourgeat, P., Huang, K., et al. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.83 · Cited by 21

Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease

Xia, Y., Doré, V., Fripp, J., Bourgeat, P., Laws, S. M., Fowler, C. J., Rainey‐Smith, S. R., Martins, R. N., Rowe, C. C., Masters, C. L., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209626 · Cited by 24

Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries

Xu, X., Kwon, J., Yan, R., Apio, C., Song, S. C., Heo, G., Yang, Q., Timsina, J., Liu, M., Budde, J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0562 · Cited by 30

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig, K., Willemse, E. A. J., Sánchez‐Juan, P., Rábano, A., Martinez-Castillo, M., Doecke, J. D., Bellomo, G., Vermunt, L., Alcolea, D. A., Halbgebauer, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56293-z · Cited by 23

Abdominal aortic calcification on lateral spine images captured during bone density testing and late-life dementia risk in older women: A prospective cohort study

Porter, T., Sim, M., Prince, R. L., Schousboe, J. T., Bondonno, C. P., Lim, W. H., Zhu, K., Kiel, D. P., Hodgson, J. M., Laws, S. M., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100502 · Cited by 20

Visually Identified Tau 18 F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease

Krishnadas, N., Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215558 · Cited by 20

Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume

Pedrini, S., Doecke, J. D., Hone, E., Wang, P., Thota, R. N., Bush, A. I., Rowe, C. C., Doré, V., Villemagne, V. L., Ames, D. J., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15681 · Cited by 20

Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease

White, J. P., Schembri, A. J., Prenn-Gologranc, C., Ondrus, M., Katina, S., Novák, P., Lim, Y. Y., Edgar, C. J., & Maruff, P. T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230352 · Cited by 19

A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer's Disease

Piccirella, S., Neste, L. V., Fowler, C., Masters, C. L., Fripp, J., Doecke, J. D., Xiong, C., Uberti, D. L., & Kinnon, P. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.52 · Cited by 17

Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras

Gillman, A., Bourgeat, P., Cox, T. O., Villemagne, V. L., Fripp, J., Huang, K., Williams, R. C., Shishegar, R., O'Keefe, G. J., Li, S., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241313063 · Cited by 17

Habitual dietary nitrate intake and cognition in the Australian Imaging, Biomarkers and Lifestyle Study of ageing: A prospective cohort study

Rajendra, A., Bondonno, N. P., Murray, K., Zhong, L., Rainey‐Smith, S. R., Gardener, S. L., Blekkenhorst, L. C., Ames, D. J., Maruff, P. T., Martins, R. N., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.05.022 · Cited by 17

The relationship between objective physical activity and change in cognitive function

Sewell, K. R., Rainey‐Smith, S. R., Peiffer, J. J., Sohrabi, H. R., Taddei, K., Ames, D. J., Maruff, P. T., Masters, C. L., Rowe, C. C., Martins, R. N., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12950 · Cited by 19

SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and susceptibility-weighted MRI

Tsuchida, A., Goubet, M., Boutinaud, P., Astafeva, I., Nozais, V., Hervé, P., Tourdias, T., Debette, S., & Joliot, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-81870-5 · Cited by 19

Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults

Slee, M. G., Rainey‐Smith, S. R., Villemagne, V. L., Doecke, J. D., Sohrabi, H. R., Taddei, K., Ames, D. J., Doré, V., Maruff, P. T., Laws, S. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13556 · Cited by 17

Plasma biomarkers in chronic single moderate–severe traumatic brain injury

Spitz, G., Hicks, A. J., McDonald, S. J., Doré, V., Krishnadas, N., O'Brien, T. J., O’Brien, W. T., Vivash, L. E., Law, M., Ponsford, J. L., et al. (2024) · Brain · doi:10.1093/brain/awae255 · Cited by 16

Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease

Senesi, M., Lewis, V., Varghese, S., Stehmann, C., McGlade, A. R., Doecke, J. D., Ellett, L. J., Sarros, S., Fowler, C. J., Masters, C. L., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1072952 · Cited by 15

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer’s disease progression

Zhang, S., Yuan, J., Sun, Y., Wu, F., Liu, Z., Zhai, F., Zhang, Y., Somekh, J., Mor Peleg, B., Zhu, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110263 · Cited by 17

No Influence of Age-Related Hearing Loss on Brain Amyloid-β

Sarant, J. Z., Harris, D. C., Busby, P. A., Fowler, C., Fripp, J., Masters, C. L., & Maruff, P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215121 · Cited by 19

Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels

Woodfield, A., Porter, T., Gilani, I., Noordin, S., Li, Q., Collins, S. J., Martins, R. N., Maruff, P. T., Masters, C. L., Rowe, C. C., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.004 · Cited by 18

Impaired muscle function, including its decline, is related to greater long‐term late‐life dementia risk in older women

Radavelli‐Bagatini, S., Macpherson, H., Scott, D. S., Daly, R. M., Hodgson, J. M., Laws, S. M., Zhu, K., Prince, R. L., Lewis, J. R., & Sim, M. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13227 · Cited by 14

Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ− and Aβ+ Older Adults

Rosenich, E., Bransby, L., Yassi, N., Fripp, J., Laws, S. M., Martins, R. N., Fowler, C. J., Rainey‐Smith, S. R., Rowe, C. C., Masters, C. L., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200118 · Cited by 13

Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer’s Disease

Li, Y., Huang, X., Fowler, C. J., Lim, Y. Y., Laws, S. M., Faux, N. G., Doecke, J. D., Trounson, B. O., Pertile, K. K., Rumble, R. L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147867 · Cited by 14

Elucidating the Link Between Anxiety/Depression and Alzheimer’s Dementia in the Australian Imaging Biomarkers and Lifestyle (AIBL) Study

Ma, L., Tan, E. C. K., Bush, A. I., Masters, C. L., Goudey, B., Jin, L., & Pan, Y. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00266-w · Cited by 13

Enhancing Alzheimer’s Disease Detection through Ensemble Learning of Fine-Tuned Pre-Trained Neural Networks

Topsakal, O., & Lenkala, S. (2024) · Electronics · doi:10.3390/electronics13173452 · Cited by 12

COCHLEA: Longitudinal Cognitive Performance of Older Adults with Hearing Loss and Cochlear Implants at 4.5-Year Follow-Up

Sarant, J. Z., Busby, P. A., Schembri, A. J., Briggs, R., Masters, C. L., & Harris, D. (2024) · Brain Sciences · doi:10.3390/brainsci14121279 · Cited by 12

DeepResBat: Deep residual batch harmonization accounting for covariate distribution differences

An, L., Zhang, C., Wulan, N., Zhang, S., Chen, P., Ji, F., Ng, K. K., Chen, C., Zhou, J. H., Yeo, B. T. T., et al. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103354 · Cited by 10

Alzheimer’s disease biological PET staging using plasma p217+tau

Feizpour, A., Doré, V., Krishnadas, N., Bourgeat, P., Doecke, J. D., Saad, Z. S., Triana‐Baltzer, G., Laws, S. M., Shishegar, R., Huang, K., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00768-z · Cited by 16

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases

Krishnadas, N., Doré, V., Laws, S. M., Porter, T., Lamb, F., Bozinovski, S., Villemagne, V. L., & Rowe, C. C. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12326 · Cited by 10

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer’s Disease

Hackenhaar, F. S., Study, T. A. I. B. A. L., Josefsson, M., Adolfsson, A. N., Landfors, M., Kauppi, K., Porter, T., Milicic, L., Laws, S. M., Hultdin, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230039 · Cited by 10

Alzheimer’s disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults

Soldan, A., Wang, J., Pettigrew, C. A., Davatzikos, C. A., Erus, G., Hohman, T. J., Dumitrescu, L. C., Bilgel, M., Resnick, S. M., Rivera‐Rivera, L. A., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae276 · Cited by 10

Investigating Genetic Overlap between Alzheimer’s Disease, Lipids, and Coronary Artery Disease: A Large-Scale Genome-Wide Cross Trait Analysis

Kirby, A., Porter, T., Adewuyi, E. O., & Laws, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168814 · Cited by 11

Development and validation of the Florey Dementia Risk Score web-based tool to screen for Alzheimer's disease in primary care

Pan, Y., Chu, C., Wang, Y., Wang, Y., Ji, G., Masters, C. L., Goudey, B., & Jin, L. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102834 · Cited by 11

Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia

Chu, C., Wang, Y., Wang, Y., Fowler, C. J., Zisis, G., Masters, C. L., Doecke, J. D., Goudey, B., Jin, L., Pan, Y., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.53756 · Cited by 11

Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer’s disease

Xia, Y., Maruff, P. T., Doré, V., Bourgeat, P., Laws, S. M., Fowler, C. J., Rainey‐Smith, S. R., Martins, R. N., Villemagne, V. L., Rowe, C. C., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.09.002 · Cited by 12

Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyPreprint

Ossenkoppele, R., Salvadó, G., Janelidze, S., Binette, A. P., Bali, D., Karlsson, L., Palmqvist, S., Mattsson, N., Stomrud, E., Therriault, J., et al. (2024) · medRxiv · doi:10.1101/2024.06.12.24308824 · Cited by 10

Brain-ID: Learning Contrast-Agnostic Anatomical Representations for Brain Imaging

Liu, P., Puonti, O., Hu, X., Alexander, D. C., & Iglesias, J. E. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-73254-6_19 · Cited by 12

Multimodal Self-Supervised Learning for Early Alzheimer’s: Cross-Modal MRI–PET, Longitudinal Signals, and Site Invariance

Ali, S. B., Ghannam, N. E., Mancy, H., & Elkilany, B. G. (2025) · Diagnostics · doi:10.3390/diagnostics15243135 · Cited by 9

Causal functional connectivity in Alzheimer's disease computed from time series fMRI data

Biswas, R., & Sripada, S. (2023) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2023.1251301 · Cited by 8

Gut Microbial Composition and Short-Chain Fatty Acid Metabolism in Cognitively Unimpaired Adults Stratified by Amyloid-β Status

Dissanayaka, D. M. S., Jayasinghe, T. N., Sohrabi, H. R., Rainey‐Smith, S. R., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Biomolecules · doi:10.3390/biom16010018 · Cited by 8

Exploring sexual dimorphism in basal forebrain volume changes during aging and neurodegenerative diseases

Shi, Y., Cui, D., Sun, F., OuYang, Z., Dou, R., Jiao, Q., Cao, W., & Yu, G. (2024) · iScience · doi:10.1016/j.isci.2024.109041 · Cited by 8

Cross‐Dataset Evaluation of Dementia Longitudinal Progression Prediction Models

Zhang, C., An, L., Wulan, N., Nguyen, K., Orbán, C., Chen, P., Chen, C., Zhou, J. H., Liu, K., Yeo, B. T. T., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70280 · Cited by 9

Mind the Gap: Does Brain Age Improve Alzheimer’s Disease Prediction?

Tan, T. W. K., Nguyen, K., Zhang, C., Kong, R., Cheng, S. F., Ji, F., Chong, J. S. X., Chong, E. J. Y., Venketasubramanian, N., Orbán, C., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70276 · Cited by 10

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report

Pepe, M., Nicola, M. D., Cocciolillo, F., Chiappini, S., Martinotti, G., Calcagni, M. L., & Sani, G. (2024) · Pharmaceuticals · doi:10.3390/ph17040452 · Cited by 8

Baseline habitual dietary nitrate intake and Alzheimer's Disease related neuroimaging biomarkers in the Australian Imaging, Biomarkers and Lifestyle study of ageing

Rajendra, A., Bondonno, N. P., Murray, K., Zhong, L., Rainey‐Smith, S. R., Gardener, S. L., Blekkenhorst, L. C., Doré, V., Villemagne, V. L., Laws, S. M., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100161 · Cited by 7

Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease

Huang, X., Li, Y., Fowler, C. J., Doecke, J. D., Lim, Y. Y., Drysdale, C., Zhang, V., Park, K., Trounson, B. O., Pertile, K. K., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12813 · Cited by 7

Advancements and challenges in using AI for biomarker detection in early Alzheimer’s disease

Beheshti, I., Albensi, B. C., Freitas, A. A., & Ghafourian, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104415 · Cited by 9

Overview of Challenges in Brain-Based Predictive Modeling: Toward Meaningful Predictive Insights

Komeyer, V., Nieto, N., Eickhoff, S. B., Raimondo, F., & Patil, K. R. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.09.003 · Cited by 6

Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer’s disease using ADNI

Elhefnawy, M. E., Patson, N., Mouksassi, S., Pillai, G. C., Shcherbinin, S., Chigutsa, E., & Gueorguieva, I. (2025) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-024-09959-y · Cited by 6

Epigenetic age acceleration in peripheral blood correlates with brain-MRI age acceleration

Ferreira, P. S. B., van Dongen, J., den Braber, A., Boomsma, D. I., de Geus, E. J. C., & Ent, D. V. ‘. (2025) · Brain · doi:10.1093/brain/awaf069 · Cited by 8

A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty

White, J. P., Schembri, A. J., Edgar, C. J., Lim, Y. Y., Masters, C. L., & Maruff, P. T. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.780303 · Cited by 7

Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease

Vacher, M. A., Doré, V., Porter, T., Milicic, L., Villemagne, V. L., Bourgeat, P., Burnham, S. C., Cox, T. O., Masters, C. L., Rowe, C. C., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08617-2 · Cited by 6

Stable potassium isotope ratios in human blood serum towards biomarker development in Alzheimer's disease

Mahan, B., Hu, Y., Lahoud, E., Nestmeyer, M., McCoy-West, A., Manestar, G. N., Fowler, C. J., Bush, A. I., & Moynier, F. (2024) · Metallomics · doi:10.1093/mtomcs/mfae038 · Cited by 5

Therapeutic Efficacy of Extracellular Vesicles Derived from Stem Cell for Alzheimer's Disease: A Meta-Analysis Study

Deng, H., Zhao, J., Li, J., Chen, C., Hu, Z., Wu, X., & Ge, L. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2909340 · Cited by 6

The moderating effect of dietary patterns on the association of depression and anxiety with cognitive function

Shamsi, H. S. S. A., Gardener, S. L., Sohrabi, H. R., Taddei, K., Masters, C. L., Rainey‐Smith, S. R., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.013 · Cited by 6

MethylGenotyper: Accurate Estimation of SNP Genotypes and Genetic Relatedness from DNA Methylation Data

Jiang, Y. W., Qu, M., Jiang, M., Jiang, X., Fernandez, S., Porter, T., Laws, S. M., Masters, C. L., Guo, H., Cheng, S., et al. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae044 · Cited by 5

Health system learning enables generalist neuroimaging models

Kondepudi, A., Rao, A. T., Zhao, C., Lyu, Y., Harake, E. S., Banerjee, S., Ogle, J. D., Joshi, R. S., Meißner, A.-K., Hou, X., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04497-1 · Cited by 17

Predicting amyloid beta accumulation in cognitively unimpaired older adults: Cognitive assessments provide no additional utility beyond demographic and genetic factors

Liu, S., Maruff, P. T., Saint‐Jalmes, M., Bourgeat, P., Masters, C. L., Goudey, B., & for the Alzheimer's Disease Neuroimaging Initiative, A. T. A. I. B. A. L. F. S. O. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70036 · Cited by 7

Association of plastic-associated chemicals with Alzheimer's disease amyloid-β and cognitive status

Cánovas, R., Doecke, J. D., Fowler, C. J., Fripp, J., Wang, X., Mueller, J. F., Jayarathne, A., He, C., Elagali, A. E. M., Dunlop, S. A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364559 · Cited by 4

The role of diet in moderating the relationship between symptoms of depression and brain amyloid load

Shamsi, H. S. S. A., Gardener, S. L., Rainey‐Smith, S. R., Sohrabi, H. R., Taddei, K., Masters, C. L., Doré, V., Rowe, C. C., Fernando, W. M. A. D. B., & Martins, R. N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70560 · Cited by 4

Unraveling Normal Anatomy via Fluid-Driven Anomaly Randomization

Liu, P., Aguila, A. L., & Iglesias, J. E. (2025) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52734.2025.00978 · Cited by 4

The moderating effect of diet on the relationship between depressive symptoms and Alzheimer’s disease-related blood-based biomarkers

Shamsi, H. S. S. A., Gardener, S. L., Rainey‐Smith, S. R., Pedrini, S., Sohrabi, H. R., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.01.003 · Cited by 3

Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer’s disease dementia prognosis

Gascón‐Bayarri, J., Mosquera, J. L., Blanch, M., Martí, P., Fontal, B., Trapero, C., Rojo, N., Rico, I., Campdelacreu, J., Fowler, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113418 · Cited by 3

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly

Honey, M. I. J., van Maurik, I. S., van Harten, A. C., Gouda, M., van Leeuwenstijn, M. S. S. A., Mank, A., Trieu, C., Bouteloup, V., Chêne, G., Pellegrin, I., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01925-1 · Cited by 5

“Brain health”—the emergence of a new healthy construct and its role in everyday life

Siette, J., Knaggs, G. T., & Singh, S. (2025) · The Gerontologist · doi:10.1093/geront/gnaf288 · Cited by 4

Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans

Feizpour, A., Doré, V., Bourgeat, P., Doecke, J. D., Cánovas, R., Laws, S. M., Porter, T., Huang, K., Fowler, C. J., Martins, R. N., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100455 · Cited by 4

Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories

Cánovas, R., Fowler, C. J., Feizpour, A., Doré, V., Bourgeat, P., Saad, Z. S., Triana‐Baltzer, G., Kolb, H. C., Vandijck, M. L. J., Kollmorgen, G., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71145 · Cited by 3

An inverse association of cerebral amyloid-β deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan

Sekikawa, A. M., Higashiyama, A., Lopresti, B. J., Ihara, M., Cui, C., Li, J., Watanabe, M., Li, M., Goon, S., Aizenstein, H. J., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251340688 · Cited by 3

NDDRF 2.0: An update and expansion of risk factor knowledge base for personalized prevention of neurodegenerative diseases

Bi, C., Zheng, X. H., Zhang, Y., Zhou, S., Song, J., Shang, H., & Shen, B. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70282 · Cited by 2

Amyloid-β protein precursor fragments in urine: Potential biomarkers for the early detection of mild cognitive impairment and dementia

Zhu, J., Xiao, X., Chen, X., Xiao, H., Tao, Z., Zhang, H., Park, K., Lam, L. Q., Thai, C., Trouson, B., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352213 · Cited by 3

Towards practical Alzheimer’s Disease diagnosis: A lightweight and interpretable spiking neural model

Wu, C., Chen, Y., Du, Y., Zong, J., Dong, J., Liu, M., Qin, F., Peng, Y. K., Fan, J., & Wang, C. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.109595 · Cited by 3

Evidence for direct and sleep‐moderated relationships between aquaporin‐4 genetic variants and Alzheimer's disease phenotypes

Porter, T., Armstrong, A. M., O’Brien, E. K., Doré, V., Bourgeat, P., Turner, M., Maruff, P. T., Rowe, C. C., Brown, B. M., Villemagne, V. L., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71516 · Cited by 3

Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: An update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study

Ellis, K. A., Rainey‐Smith, S. R., Rembach, A., Macaulay, S. L., Villemagne, V. L., & Aibl research group (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.870136 · Cited by 17

P2‐178: Findings from the first 18‐month follow up of the Australian Imaging Biomarkers and Lifestyle (AIBL) cohort

Ellis, K. A., Bush, A. I., Foster, J. K., Martins, R. N., Maruff, P. T., Masters, C. L., Rowe, C. C., Savage, G. R., Szoeke, C. E. I., & Ames, D. J. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1226

Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative

Ellis, K. A., Rowe, C. C., Villemagne, V. L., Martins, R. N., Masters, C. L., Salvado, O., Szoeke, C. E. I., & Ames, D. J. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.009 · Cited by 73

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005

IC‐P‐013: The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers

Szoeke, C. E. I., Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.033